Shin Poong Pharm.Co.,Ltd. (019170.KS)
019170.KS Stock Price Chart
Explore Shin Poong Pharm.Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 019170.KS price movements and trends.
019170.KS Company Profile
Discover essential business fundamentals and corporate details for Shin Poong Pharm.Co.,Ltd. (019170.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
815.00
Website
https://shinpoong.co.krCEO
Jei-Man Ryu
Description
Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.
019170.KS Financial Timeline
Browse a chronological timeline of Shin Poong Pharm.Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 20 Feb 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at ₩63.78 , while revenue for the quarter reached ₩58.62B .
Earnings released on 15 May 2025
EPS came in at -₩26.00 , while revenue for the quarter reached ₩55.41B .
Earnings released on 21 Feb 2025
EPS came in at -₩246.55 , while revenue for the quarter reached ₩55.26B .
Earnings released on 15 Nov 2024
EPS came in at -₩10.00 , while revenue for the quarter reached ₩55.80B .
Earnings released on 14 Aug 2024
EPS came in at -₩1.03 , while revenue for the quarter reached ₩56.03B , beating expectations by +31.03K%.
Earnings released on 16 May 2024
EPS came in at -₩50.67 , while revenue for the quarter reached ₩54.01B , beating expectations by +29.90K%.
Earnings released on 21 Mar 2024
EPS came in at -₩648.44 , while revenue for the quarter reached ₩49.61B , beating expectations by +27.46K%.
Earnings released on 15 Nov 2023
EPS came in at -₩157.07 , while revenue for the quarter reached ₩49.13B , beating expectations by +27.20K%.
Earnings released on 14 Aug 2023
EPS came in at -₩175.53 , while revenue for the quarter reached ₩53.12B , beating expectations by +29.41K%.
Earnings released on 15 May 2023
EPS came in at -₩136.85 , while revenue for the quarter reached ₩48.37B , beating expectations by +26.77K%.
Earnings released on 23 Mar 2023
EPS came in at -₩331.56 , while revenue for the quarter reached ₩58.79B , beating expectations by +32.56K%.
Earnings released on 9 Mar 2023
EPS came in at -₩188.78 , while revenue for the quarter reached ₩53.38B , beating expectations by +29.55K%.
Earnings released on 30 Jun 2022
EPS came in at -₩92.93 , while revenue for the quarter reached ₩50.37B .
Earnings released on 31 Mar 2022
EPS came in at -₩107.62 , while revenue for the quarter reached ₩46.75B .
Earnings released on 21 Mar 2022
EPS came in at -₩226.25 , while revenue for the quarter reached ₩49.71B .
Earnings released on 15 Nov 2021
EPS came in at ₩8.00 , while revenue for the quarter reached ₩46.17B .
Earnings released on 30 Sept 2021
EPS came in at -₩39.00 , while revenue for the quarter reached ₩48.39B .
Earnings released on 31 Mar 2021
EPS came in at ₩28.00 , while revenue for the quarter reached ₩44.97B .
Earnings released on 22 Mar 2021
EPS came in at ₩9.37 , while revenue for the quarter reached ₩49.33B .
Dividend declared on 29 Dec 2020
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 23 Apr 2021.
Earnings released on 16 Nov 2020
EPS came in at ₩19.00 , while revenue for the quarter reached ₩48.10B .
019170.KS Stock Performance
Access detailed 019170.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.